https://scholars.lib.ntu.edu.tw/handle/123456789/636411
標題: | Dipeptidyl peptidase IV inhibitors and the risk of mycobacterial pulmonary infections in type 2 diabetes mellitus | 作者: | Wang, Cheng-Yi Liao, Kuang-Ming Wang, Ya-Hui Chen, Kuang-Hung Chuang, Shulin CHIA-JUNG LIU CHIN-CHUNG SHU HAO-CHIEN WANG |
關鍵字: | Diabetes mellitus; Dipeptidyl peptidase IV inhibitors; Mycobacterial pulmonary infection; Nontuberculous mycobacterial lung disease; Tuberculosis | 公開日期: | 26-八月-2023 | 卷: | 16 | 期: | 11 | 起(迄)頁: | 1709 | 來源出版物: | Journal of infection and public health | 摘要: | Type 2 diabetes mellitus (DM) is a risk factor for mycobacterial pulmonary infections (MPI), including tuberculosis (TB) and nontuberculous mycobacterial lung disease (NTM-LD). Dipeptidyl peptidase IV inhibitor (DPP4i), a common DM medication, has an immune-modulation effect that raises concerns about developing MPI. However, there is scarce research on the topic. |
URI: | https://pubmed.ncbi.nlm.nih.gov/37729686/ https://scholars.lib.ntu.edu.tw/handle/123456789/636411 |
ISSN: | 18760341 | DOI: | 10.1016/j.jiph.2023.08.018 |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。